Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes A 24-week, randomized, double-blind, placebo-controlled trial

DSpace Repository

Empagliflozin as Add-on to Metformin Plus Sulfonylurea in Patients With Type 2 Diabetes A 24-week, randomized, double-blind, placebo-controlled trial

Author: Haering, Hans-Ulrich; Merker, Ludwig; Seewaldt-Becker, Elke; Weimer, Marc; Meinicke, Thomas; Woerle, Hans J.; Broedl, Uli C.
Tübinger Autor(en):
Häring, Hans-Ulrich
Published in: Diabetes Care (2013), Bd. 36, H. 11, S. 3396-3404
Verlagsangabe: Amer Diabetes Assoc
Language: English
Full text: http://dx.doi.org/10.2337/dc12-2673
ISSN: 0149-5992
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)